BioCentriq
Sridevi Navuduri Viswanatha has extensive experience in the biopharmaceutical and research sectors, currently serving as the Analytical Operation and Quality Control Senior Manager at BioCentriq since March 2022. Previous roles include positions as a Senior Scientist in Cell and Gene Therapy at IO Biosciences, a Translational Medicine Scientist at Bristol Myers Squibb, and a Bio Analytical Scientist at Covance. Sridevi has also held managerial and research roles at the Multiple Sclerosis Research Institute, Pixel Systems, Inc., and Duke Medical Center, among others. Educational qualifications include a Master’s in Biotechnology from Jawaharlal Nehru Technological University, a Molecular Biology Certificate from Montclair State University, and a Bachelor’s in Microbiology from Osmania University, along with a Master’s in Biochemistry from the University of Mysore.
This person is not in any offices
BioCentriq
Established in 2019, BioCentriq is a full-service, New Jersey-based CDMO for cell and gene therapy, focusing on all stages of process development and clinical manufacturing. With over 90 scientists, engineers, analysts, and manufacturing specialists, we have the quality systems and infrastructure required to support the release of both autologous and allogeneic drug products. BioCentriq also specializes in viral vector process development and manufacturing with expertise in a variety of cell and vector types. Our 35,000 square feet of facilities includes four, soon to be five, ISO-7 certified GMP manufacturing suites, a fully equipped process development laboratory, quality control and analytical method development laboratories, and training facilities. We also operate the only McKinsey-owned Innovation & Learning Center designed to explore the application of industry 4.0, digital and lean manufacturing disciplines to life sciences.